Skip to main content

Closed

FHTX: Foghorn Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-286.2%

ROIC-50.6%

Financially safe

Stretched

Debt / equity-0.55×

Interest coverage0.0×

Current ratio2.92×

Foghorn Therapeutics Inc.

FHTXNASDAQ Global Market·USD·Closed

Foghorn Therapeutics Inc.

FHTXNASDAQ·USD·Closed

$4.53

−4.43%

$4.53

−$0.21 (4.43%)

52W Range

34thpctl

Volume

0.64×avg

Mkt Cap

265.97MUSD

P/E

-3.9TTM

Div Yield

–ann

52W Range

34thpctl

Volume

0.64×avg

Market Cap

265.97MUSD

P/E Ratio

-3.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings